Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes

JJ. van Dongen, L. Lhermitte, S. Böttcher, J. Almeida, VH. van der Velden, J. Flores-Montero, A. Rawstron, V. Asnafi, Q. Lécrevisse, P. Lucio, E. Mejstrikova, T. Szczepański, T. Kalina, R. de Tute, M. Brüggemann, L. Sedek, M. Cullen, AW....

. 2012 ; 26 (9) : 1908-1975.

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc14082865

Grantová podpora
NS10480 MZ0 CEP - Centrální evidence projektů
NT12425 MZ0 CEP - Centrální evidence projektů

Most consensus leukemia & lymphoma antibody panels consist of lists of markers based on expert opinions, but they have not been validated. Here we present the validated EuroFlow 8-color antibody panels for immunophenotyping of hematological malignancies. The single-tube screening panels and multi-tube classification panels fit into the EuroFlow diagnostic algorithm with entries defined by clinical and laboratory parameters. The panels were constructed in 2-7 sequential design-evaluation-redesign rounds, using novel Infinicyt software tools for multivariate data analysis. Two groups of markers are combined in each 8-color tube: (i) backbone markers to identify distinct cell populations in a sample, and (ii) markers for characterization of specific cell populations. In multi-tube panels, the backbone markers were optimally placed at the same fluorochrome position in every tube, to provide identical multidimensional localization of the target cell population(s). The characterization markers were positioned according to the diagnostic utility of the combined markers. Each proposed antibody combination was tested against reference databases of normal and malignant cells from healthy subjects and WHO-based disease entities, respectively. The EuroFlow studies resulted in validated and flexible 8-color antibody panels for multidimensional identification and characterization of normal and aberrant cells, optimally suited for immunophenotypic screening and classification of hematological malignancies.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14082865
003      
CZ-PrNML
005      
20250108115554.0
007      
ta
008      
141217s2012 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/leu.2012.120 $2 doi
035    __
$a (PubMed)22552007
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a van Dongen, J J M
245    10
$a EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes / $c JJ. van Dongen, L. Lhermitte, S. Böttcher, J. Almeida, VH. van der Velden, J. Flores-Montero, A. Rawstron, V. Asnafi, Q. Lécrevisse, P. Lucio, E. Mejstrikova, T. Szczepański, T. Kalina, R. de Tute, M. Brüggemann, L. Sedek, M. Cullen, AW. Langerak, A. Mendonça, E. Macintyre, M. Martin-Ayuso, O. Hrusak, MB. Vidriales, A. Orfao
520    9_
$a Most consensus leukemia & lymphoma antibody panels consist of lists of markers based on expert opinions, but they have not been validated. Here we present the validated EuroFlow 8-color antibody panels for immunophenotyping of hematological malignancies. The single-tube screening panels and multi-tube classification panels fit into the EuroFlow diagnostic algorithm with entries defined by clinical and laboratory parameters. The panels were constructed in 2-7 sequential design-evaluation-redesign rounds, using novel Infinicyt software tools for multivariate data analysis. Two groups of markers are combined in each 8-color tube: (i) backbone markers to identify distinct cell populations in a sample, and (ii) markers for characterization of specific cell populations. In multi-tube panels, the backbone markers were optimally placed at the same fluorochrome position in every tube, to provide identical multidimensional localization of the target cell population(s). The characterization markers were positioned according to the diagnostic utility of the combined markers. Each proposed antibody combination was tested against reference databases of normal and malignant cells from healthy subjects and WHO-based disease entities, respectively. The EuroFlow studies resulted in validated and flexible 8-color antibody panels for multidimensional identification and characterization of normal and aberrant cells, optimally suited for immunophenotypic screening and classification of hematological malignancies.
650    _2
$a monoklonální protilátky $x diagnostické užití $7 D000911
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a průtoková cytometrie $x normy $7 D005434
650    _2
$a hematologické nádory $x diagnóza $x imunologie $7 D019337
650    _2
$a lidé $7 D006801
650    _2
$a imunofenotypizace $x normy $7 D016130
650    _2
$a leukocyty $x imunologie $x patologie $7 D007962
650    _2
$a prognóza $7 D011379
650    _2
$a nádorové biomarkery $x imunologie $7 D014408
651    _2
$a Evropa $7 D005060
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Lhermitte, L
700    1_
$a Böttcher, Sebastian, $d 1971- $7 xx0327357
700    1_
$a Almeida, J $7 gn_A_00004623
700    1_
$a van der Velden, V H J
700    1_
$a Flores-Montero, J
700    1_
$a Rawstron, A
700    1_
$a Asnafi, V $7 gn_A_00009462
700    1#
$a Lécrevisse, Q
700    1_
$a Lucio, P
700    1_
$a Mejstříková, Ester, $d 1977- $7 xx0105223
700    1_
$a Szczepański, T
700    1_
$a Kalina, Tomáš, $d 1975 říjen 11.- $7 xx0060125
700    1_
$a de Tute, R
700    1_
$a Brüggemann, M
700    1_
$a Sedek, L
700    1_
$a Cullen, M
700    1_
$a Langerak, A W
700    1_
$a Mendonça, A
700    1_
$a Macintyre, E
700    1_
$a Martin-Ayuso, M
700    1_
$a Hrušák, Ondřej, $d 1965- $7 xx0036691
700    1_
$a Vidriales, M B
700    1_
$a Orfao, A
773    0_
$w MED00003138 $t Leukemia $x 1476-5551 $g Roč. 26, č. 9 (2012), s. 1908-1975
856    41
$u https://pubmed.ncbi.nlm.nih.gov/22552007 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20141217 $b ABA008
991    __
$a 20250108115550 $b ABA008
999    __
$a ok $b bmc $g 1051269 $s 881971
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 26 $c 9 $d 1908-1975 $i 1476-5551 $m Leukemia $n Leukemia $x MED00003138
GRA    __
$a NS10480 $p MZ0
GRA    __
$a NT12425 $p MZ0
LZP    __
$a Pubmed-20141217

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...